Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA029971 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA029971, RRID:AB_10611389
- Product name
- Anti-RECQL5
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human RECQL5, Gene description: RecQ protein-like 5, Alternative Gene Names: FLJ90603, RecQ5, Validated applications: ICC, IHC, Uniprot ID: O94762, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.4 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Low expression of RecQ‑like helicase 5 is associated with poor prognosis in patients with gastric cancer
Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy
Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers
Altered RECQ Helicase Expression in Sporadic Primary Colorectal Cancers
Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells
Altered RECQ Helicase Expression in Sporadic Primary Colorectal Cancers.
Lin Y, Wang H, Wang X, Li M, Chen H, Peng J
Oncology Letters 2019
Oncology Letters 2019
Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy
Patterson K, Arya L, Bottomley S, Morgan S, Cox A, Catto J, Bryant H
Oncotarget 2016;7(46):76140-76150
Oncotarget 2016;7(46):76140-76150
Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers
Arora A, Abdel-Fatah T, Agarwal D, Doherty R, Croteau D, Moseley P, Hameed K, Green A, Aleskandarany M, Rakha E, Patterson K, Ball G, Chan S, Ellis I, Bohr V, Bryant H, Madhusudan S
Carcinogenesis 2016;37(1):63-71
Carcinogenesis 2016;37(1):63-71
Altered RECQ Helicase Expression in Sporadic Primary Colorectal Cancers
Lao V, Welcsh P, Luo Y, Carter K, Dzieciatkowski S, Dintzis S, Meza J, Sarvetnick N, Monnat R, Loeb L, Grady W
Translational Oncology 2013;6(4):458-IN10
Translational Oncology 2013;6(4):458-IN10
Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells
Stadler C, Rexhepaj E, Singan V, Murphy R, Pepperkok R, Uhlén M, Simpson J, Lundberg E
Nature Methods 2013;10(4):315-323
Nature Methods 2013;10(4):315-323
Altered RECQ Helicase Expression in Sporadic Primary Colorectal Cancers.
Lao VV, Welcsh P, Luo Y, Carter KT, Dzieciatkowski S, Dintzis S, Meza J, Sarvetnick NE, Monnat RJ Jr, Loeb LA, Grady WM
Translational oncology 2013 Aug;6(4):458-69
Translational oncology 2013 Aug;6(4):458-69
No comments: Submit comment
Enhanced validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- Western blot analysis in A-549 cells transfected with control siRNA, target specific siRNA probe #1 and #2, using Anti-RECQL5 antibody. Remaining relative intensity is presented. Loading control: Anti-GAPDH.
- Sample type
- Human
- Protocol
- Protocol
